A study that investigated the development of NAFLD in Chinese subjects revealed a close correlation of serum LCN2 with the progression of the disease and the occurrence of insulin resistance (Ye et al., 2014). The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.